Effect of Tomato Juice Supplements Consumption on the Lipid Profile of Dyslipidemia Patients by Sugini,
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books







Effect of Tomato Juice 
Supplements Consumption on 




The objective of this study was to determine the effect of tomato juice 
 supplements consumption on the lipid profile of women with dyslipidemia 
patients. The design of this study was a quasi-control experimental design with 
pre-post test. The subjects were sixty-two Kendal Hospital women employees, aged 
35–50 years old, suffering from dyslipidemia but did not suffer from metabolic or 
degenerative diseases based on the examination of a specialist in internal medicine. 
Subjects were divided into two groups, group I (30 people) were given antioxidant 
supplements (336 g of tomatoes per day) for 21 days and group II (32 people) as 
control. The nutrition intake data was measured by the 24-hour food withdrawal 
method conducted for three consecutive days in three weeks of research calculated 
by the Nutrisurvey program. Data was analyzed with Kolmogorov Smirnov test, 
Pearson test and Mann Whitney test. There were significant relationships between 
energy intake, protein intake, fat intake, and carbohydrate intake with total cho-
lesterol levels and triglyceride levels and there were also significant relationships 
between energy intake and fat intake with low density lipoprotein levels. It shows 
that there is a relationship between diet and dyslipidemia. There were significant 
differences in total cholesterol, low lipoprotein levels and triglycerides in treatment 
and control groups. This showed that tomato juice supplements significantly affect 
the lipid profiles.
Keywords: diet, tomato juice supplements, lipid profile, cardiovascular disease
1. Introduction
The relationship between blood cholesterol and heart disease has been well-
established, with a decrease in Cholesterol Low Density Lipoprotein (LDL) being 
the main target of preventive therapy. High levels of LDL cholesterol in blood 
vessels cause these molecules to penetrate the sub-endothelial space which can 
be easily oxidized by free radicals. This oxidized LDL causes damage to nearby 
structures, causing the recruitment of monocytes to eliminate the oxidized LDL. 
This elimination process produces by-products in the form of foam cells. These 
foam cells release toxins that cause damage to endothelium cells, hypertrophy, and 
smooth muscle hyperplasia of blood vessels. This process also stimulates platelet 
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aggregation which can interfere with the production or availability of nitric oxide 
which results in decreased blood vessel lumen and ischemia in tissues and organs. 
As this inflammatory process develops, high LDL cholesterol levels can develop into 
atherosclerosis [1].
Cardiovascular disease (CVD) is a leading cause of human disability and 
premature death worldwide. Diet has a direct relationship with the development 
of CVD and dietary changes are the current approach CVD prevention which is to 
increase consumption of fruits and vegetables as a good source of some antioxidant 
phytochemicals, e.g. carotenoids. Lycopene is the most abundant carotenoid in 
tomatoes and tomato products have gained profuse attention in recent years for 
their beneficial of health role, especially those related to their antioxidant effects 
and its protective role against CVD [2]. Dietary and antioxidant supplements are 
efforts to prevent the development of dyslipidemia into cardiovascular disease. 
The 2015 US Diet Guidelines Advisory Committee summarizes the evidence for the 
benefits of a healthy diet on cardiometabolic outcomes and other diseases and also 
describes a healthy vegetarian diet, which includes more peas, soy products, nuts 
and seeds, and seeds. Whole grains but does not include meat, poultry, or seafood 
[3]. Women in the top aMed quintile have a lower risk for both Coronary Heart 
Disease (CHD) and stroke than bottom quintile (RR = 0.71 (95% CI = 0.62–0.82; 
p trend<0.0001) for CHD; RR = 0.87 (95% CI = 0.73–1.02; p trend = 0.03) for 
stroke). CVD mortality was significantly lower among women in the top quintile 
of the aMed (RR = 0.61, 95% CI = 0.49–0.76, p trend<0.0001) [4]. Lycopene 
may improve vascular function and contributes to the primary and secondary 
prevention of cardiovascular disorders. The main activity profile of lycopene 
includes anti-atherosclerotic, antioxidant, anti-inflammatory, antihypertensive, 
antiplatelet, antiapoptotic, and protective endothelial effects, the ability to improve 
the metabolic profile, and reduce arterial stiffness. In this context, lycopene has 
been shown in many studies to exert a favorable effect in patients with subclinical 
atherosclerosis, metabolic syndrome, hypertension, peripheral vascular disease, 
stroke and several other cardiovascular disorders, although the results obtained are 
sometimes inconsistent, which warrants further studies focusing on its bioactiv-
ity [5]. There was a study with randomized 36 statin treated CVD patients and 36 
healthy volunteers in a 2:1 treatment allocation ratio to either 7 mg lycopene or 
placebo daily for 2 months in a double-blind trial. Post-therapy EDV responses for 
lycopene-treated CVD patients were similar to HVs at baseline (2% lower, 95% CI: 
−30% to +30%, P = 0.85), also suggesting lycopene improved endothelial func-
tion. Lycopene supplementation improves endothelial function in CVD patients on 
optimal secondary prevention, but not in HVs [6]. Lycopene is found in many fruits 
and vegetables, there is a unique situation that more than 85% of the most domi-
nant source of lycopene in human food comes from tomatoes (Solanum lycopersicum 
esculentum Mill) and products made from tomatoes such as tomato paste, tomato 
sauce and tomato juice. The level of lycopene content in some tomato products 
varies from 8.8 μg/g in fresh tomatoes to 1200 μg/g in tomato powder. The concen-
tration of lycopene in tomatoes varies depending on the type of tomato, season, 
level of maturity. The concentration of lycopene in ripe tomato juice ranges from 
8600 to 9300 μg/100 g or three times higher than fresh tomatoes [7]. The study was 
conducted using 336 g tomato juice (350 mL) equivalent to 30 mg of lycopene with 
the same research time with a similar study in humans that is 3 weeks. The use of a 
dose of 30 mg/day based on analysis from previous studies. Studies with lycopene 
dose of 20 mg/day can significantly reduce total cholesterol, but not significantly 
in high density lipoprotein (HDL) and triglyceride (TG) [8], where studies with a 
lycopene dose 40 m/day show a positive correlation with total cholesterol, LDL, TG 
and HDL/LDL ratio, but negatively correlated with HDL [9].
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This study was conducted at the Regional General Hospital Dr. H. Soewondo 
Kendal, because cases of dyslipidemia in employees increased significantly, in 2009 
there were 67 cases and increased to 108 cases in 2012. Cases of dyslipidemia include 
hypercholesterolemia, hypertriglyceride, a combination of both, with Diabetes 
Mellitus and with other diseases. The objective of this study was to determine the 
effects of tomato juice supplement consumption on the lipid profile of dyslipidemic 
patients.
2. Materials and methods
The design of this study was a quasi-control experimental design with pre-post 
test. Subjects were sixty-two Kendal Hospital women employees, aged 35–50 years 
old, suffering from dyslipidemia but did not suffer from metabolic or degenerative 
diseases based on the examination of a specialist in internal medicine. Nutrition 
intake data was measured by 24-hour food recall method for three days in three 
weeks of the study. Nutritional values were analyzed using the Nutrisurvey pro-
gram. Food withdrawal is carried out using a food withdrawal form through inter-
views conducted by nutritionists. Subjects were divided into two groups; group I as 
the treatment group (30 people) were given with antioxidant supplements (336 g of 
tomatoes per day) for 21 days and group II (32 people) as the control group. Data on 
total cholesterol levels, LDL cholesterol levels, HDL cholesterol levels, and triglyc-
eride levels were measured using the chemical analysis system of vitros 300 system 
by clinical pathology laboratory officers of Regional Hospital Dr. H. Soewondo 
Kendal, accredited by the government. Measurements were taken before and after 
supplementation. Blood was taken at 08.00–11.00 Western Indonesian Time (WIT) 
and immediately checked the total cholesterol level, LDL cholesterol level, HDL 
cholesterol level, and triglyceride level.
Data was analyzed with Kolmogorov Smirnov test, Pearson test and Mann 
Whitney test. This research has been legalized by the Health Research Ethics 
Commission (KEPK) Faculty of Medicine, UNDIP and RSUP DR. Kariadi Semarang, 
with the issuance of “ETHICAL CLEARANCE” No. 329/EC/FK-RSDK/2014.
3. Results
In Table 1, the results showed that the profile of the study subjects did not show 
differences in age, BMI, cholesterol intake, Mono Unsaturated Fatty Acid (MUFA) 
intake, Poly Unsaturated Fatty Acid (PUFA) intake, carbohydrate intake, fiber 
intake, vitamin A intake, and vitamin C (p > 0.05). But there were differences in 
the percentage of energy intake and percentage fat intake (p < 0.05).
In Table 2 significant relationships between energy intake (P = 0.001, 
r = 0.501), fat intake (P = 0.001, r = 0.574), protein intake (P = 0.008, r = 335) 
and carbohydrate intake (P = 0.001, r = 0.446) with total cholesterol levels 
were observed. There was also a significant relationship between the fat intake 
(P = 0.012, r = 0.318) with LDL levels and there were significant relationships 
between energy intake (P = 0.005, r = 353), fat intake (P = 0.008, r = 336), protein 
intake (P = 0.016, r = 305), and carbohydrate intake (P = 0.013, r = 315) with 
triglyceride levels.
Table 3 shows the lipid profile of the study subjects before the study. There 
were no differences between the treatment group and the control group in the total 
cholesterol levels and the LDL levels (p ≥ 0.05) but, there were differences in the 
HDL levels and the triglyceride levels (p < 0.05).
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The lipid profile of the subjects after the study can be seen in Table 4. There is a 
difference between the total cholesterol and the LDL levels (p < 0.05) between the 
treatment group and the control group but no difference in the HDL levels and the 
triglyceride levels (p ≥ 0.05).
The treatment results can seen in Table 5, there were significant differences in 
total cholesterol (p = 0.001), low lipoprotein (p = 0.001) and triglyceride levels 
(p = 0.010) in the treatment and the control groups. This shows that there is a 
significant relationship between the tomato juice supplementation and lipid profile.
Variable Total Cholesterol Level LDL Level TG Level
Energy intake P = 0.001, r = 0.501 P = 0.110, r = 205 P = 0.005, r = 353
Fat intake P = 0.001,r = 0.574 P = 0.012,r = 0.318 P = 0.008, r = 336
Protein intake P = 0.008, r = 335 P = 0.449,r = 0.098 P = 0.016, r = 305
Carbohydrate intake P = 0.001, r = 0.446 P = 0.325,r = 0.127 P = 0.013 r = 315
Table 2. 
Relationship between food intake and research subject profiles.
Variable Control Group (n = 32) Treatment Group (n = 30) Value (p)
Average ± SD Average ± SD
age (th) 45.2 ± 3.4 46.3 ± 3.9 0.05a
imt(kg/m2) 27 ± 2.1 27.3 ± 3.1 0.96b
Energy intake (% REE) 124 ± 14.4 116.5 ± 13 0.04b
Fat intake (% E) 36 ± 1.7 35 ± 2.7 0.04b
Carbohydrate intake (% E) 51 ± 1.6 50.5 ± 3.8 0.30b
serat intake (gr) 23.4 ± 2.4 22.8 ± 2.9 0.22b
Choles intake (gr) 191.2 ± 27.8 199.3 ± 42.4 0.27b
Mufa intake (gr) 24.6 ± 2.7 23.6 ± 2.9 0.14b
Pufa intake (gr) 33.4 ± 3.9 31.5 ± 3.6 0.07b
vit A intake (μg) 1465.6 ± 295.6 1472.6 ± 260.8 0.49b




Characteristics of research subjects.
Variable Control Group (n = 32) Treatment Group (n = 30) Value (p)
Average ± SD Average ± SD
Chol tot pre (gr/dl) 225.9 ± 19.3 231.7 ± 24.7 0.45a
HDL pre (gr/dl) 53.8 ± 9.6 48.7 ± 11.3 0.04b
LDL pre (gr/dl) 144.9 ± 29.2 150.7 ± 23.3 0.22b




Lipid profile of subjects before in the treatment group and control group.
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4. Discussion
The average age of the subjects is 46 years, including middle-aged adults who 
are at risk of fat tissue with decreased metabolism. The older a person is, the ability 
of LDL receptors is reduced, causing blood LDL to increase. About 9% of subjects’ 
BMI were obese or an average of 27 kg/m2. Obese adults were more at risk than 
normal weight adults as they have high total cholesterol, LDL and triglyceride levels 
which is a major risk factor for coronary heart disease. Obesity, especially central 
obesity, carries a greater risk for coronary heart disease and other degenerative 
diseases and dyslipidemia. Excess Very Low Density Lipoprotein (VLDL) is pro-
duced in the liver in obese people and subsequently the VLDL is converted to LDL 
[10]. Due to that, the lipid and lipoprotein profiles of obese people are changed with 
increasing triglycerides and decreasing HDL [11].
Most of the subjects (90.3%) have high energy intake at the average of 
2300 kcal. High energy intake results in fat accumulation, especially triglycerides. 
This will increase VLDL and LDL in blood which will cause an increase in total 
cholesterol. The fat intake of the study subjects exceeded the nutritional adequacy 
rate (25–30%) i.e. the average was 34.49% in the treatment group and 35.66% in the 
control group. When a person consumes more fatty food, fat and triglyceride levels 
in the body will increase. This will increase blood VLDL and LDL [12].
Significant relationships between energy intake (P = 0.001, r = 0.501), fat intake 
(P = 0.001, r = 0.574), protein intake (P = 0.008, r = 335) and carbohydrate intake 
(P = 0.001, r = 0.446) with total cholesterol levels were observed. There was a 
significant relationship between fat intake (P = 0.012, r = 0.318) with LDL levels. 
There were significant relationships between energy intake (P = 0.005, r = 353), 
Variable Control Group (n = 32) Treatment Group (n = 30) Value p
Rerata Rerata
Chol tot post (gr/dl) 231.3 ± 24.5 202.1 ± 23.7 0.00a
HDL post (gr/dl) 54.9 ± 7.5 53.1 ± 9.7 0.23b
LDL post (gr/dl) 144.8 ± 23.5 117.5 ± 23.05 0.00b




Lipid profile of subjects after in the treatment group and control group.
Variable Treatment Group (n = 30) Control Group (n = 32) Value (p)
Average ± SD Average ± SD
d-Chol tot (gr/dl) -29.6 ± 15.2 5.3 ± 12.3 0.001a
d-HDL (gr/dl) 4.4 ± 8.9 0.83 ± 4.3 0.070b
d-LDL (gr/dl) -32.5 ± 21.8 -0.8 ± 20.1 0.001b





Changes in the lipid profile of the treatment and control group.
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fat intake (P = 0.008, r = 336), protein intake (P = 0.016, r = 305) and carbohy-
drate intake (P = 0.013, r = 315) with triglyceride levels, which is in line with this 
research. When compared with a higher-carbohydrate Dietary Approaches to Stop 
Hypertension (DASH) diet, DASH-type diet with higher protein lowered LDL by 
3.3 mg/dL, and triglycerides by 16 mg/dL. Compared with a higher-carbohydrate 
DASH diet, DASH-type diet with higher unsaturated fat lowered triglycerides 
by 10 mg/dL [13]. In a meta-analysis of 60 randomized controlled feeding trials, 
consumption of 1% of calories lowered triglycerides [14].
In a meta-analysis of four prospective cohort studies involving nearly 140,000 
subjects, including updated analyses from the two largest studies, a 2 percent 
increase in energy intake from trans fatty acids was associated with a 23 percent 
increase in the incidence of CHD (pooled relative risk, 1.23; 95 percent confidence 
interval, 1.11 to 1.37; P < 0.001) [15]. In meta-analyses of prospective cohort stud-
ies, greater consumption of refined complex carbohydrates, starches, and sugars, 
as assessed by glycemic index or load, was associated with significantly higher risk 
of CHD and DM. When the highest category (total sedentary time) was compared 
with the lowest category (short sedentary time), risk of CHD was 36% greater 
(glycemic load: RR, 1.36; 95% CI, 1.13–1.63) and risk of Diabetes Mellitus was 
40% greater (glycemic index: RR, 1.40; 95% CI, 1.23–1.59) [16, 17].
When the highest category was compared with the lowest category, dietary 
Linoleic Acid (LA) was associated with a 15% lower risk of CHD events (pooled RR, 
0.85; 95% confidence intervals, 0.78–0.92; I(2) = 35.5%) and a 21% lower risk of 
CHD deaths (pooled RR, 0.79; 95% confidence intervals, 0.71–0.89; I(2) = 0.0%). 
A 5% of energy increment in LA intake replacing energy from saturated fat intake 
was associated with a 9% lower risk of CHD events (RR, 0.91; 95% confidence 
intervals, 0.87–0.96) and a 13% lower risk of CHD deaths (RR, 0.87; 95% confi-
dence intervals, 0.82–0.94) [18].
The association suggested that replacing SFA with PUFA rather than MUFA 
or carbohydrates prevents CHD through various intakes. In comparison, in an 
analysis of individual levels collected from 11 prospective cohort studies, the 
specific exchange of PUFA consumption at SFA sites was associated with a lower 
risk of CHD, with a 13% lower risk for each 5% energy exchange (RR, 0.87; 95% CI, 
0.70–0.97 [19].
These findings provided evidence that consuming PUFA as a substitute for SFA 
reduces the incidence of CHD in RCTs. This also showed that instead of trying to 
reduce PUFA consumption, a shift towards a larger PUFA population as a substitute 
for SFA will significantly reduce the level of CHD [20].
The replacement of animal fats, including dairy fat, with vegetable sources of 
fats and PUFAs may reduce risk of CVD. whereas the 5% energy intake substitution 
of other animal fat with dairy fat was associated with 6% increased CVD risk (RR: 
1.06; 95% CI: 1.02, 1.09) [21].
There were significant differences in total cholesterol (p = 0.001), low lipopro-
tein (p = 0.001) and triglyceride levels (p = 0.010) in the treatment and control 
groups. This shows that supplementation of 336 g (350 mL) tomato juice per day for 
21 days in women with dyslipidemia with minimal risk can reduce total cholesterol 
levels by 29.6 g/dL, LDL levels by 32.5 g/dL, triglyceride levels by 41.4 g/dL.
The results of this study are in line with research by Mozaffarian et al. [20] 
which states that these findings are consistent with a meta-analysis of RCTs in 
which increased PUFA consumption in place of SFAs reduced CHD events, with 
10% lower risk for each 5% energy exchange (RR, 0.90; 95% CI, 0.83–0.97.
Among Chinese adults, a higher level of fruit consumption is associated with a 
lower risk of major cardiovascular disease [22]. Several studies have examined the 
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relationship between antioxidant intake and lipid peroxidation to try to determine 
which antioxidants play a role in preventing cardiovascular disease. The hydrocar-
bon carotenoids, including β-carotene and lycopene, are transported primarily in 
LDL, which puts them in prime position to protect LDL from oxidation [4].
Lycopene may have a cholesterol synthesis-inhibiting effect and may enhance 
LDL degradation. Available evidence suggests that intimal wall thickness and risk 
of myocardial infarction are reduced in persons with higher adipose tissue concen-
trations of lycopene [23].
Treatment with lycopene increased the ejection fraction (EF) from 45.2 ± 3.12 to 
51.1 ± 4.63, and it decreased the left ventricular at end-diastole diameter (LVEDd) 
from 6.52 ± 0.37 mm to 6.18 ± 0.41 mm and the left ventricular at end-systole 
diameter (LVESd) from 4.29 ± 0.63 to 3.94 ± 0.37 at 28 days post-myocardial 
infarction. Lycopene attenuated the MI-induced increase in MMP-9 and type I 
collagen expression, and inhibited p38 activation. Moreover, lycopene decreased 
the collagen volume fraction in the peri-infarcted zone. The data indicated that 
lycopene improved the cardiac function and ventricular remodeling by inhibit-
ing p38 activation and MMP-9 expression [24]. Lycopene can suppress VSMCs 
proliferation, due to inhibiting G1 phase cells entry into the S phase of the cell 
cycle, related to its antioxidative effect [25], and synthesis of oxidized LDL may be 
impaired by lycopene [26]. Loana et al. [5] reviewed the importance of lycopene 
in improving vascular function and in the primary and secondary prevention of 
cardiovascular disorders. The effects shown by lycopene in view of cardiovascular 
health consist of general antioxidants and anti-inflammatory, antiplatelet, anti-
apoptotic and antihypertensive properties, ability to improve endothelial function, 
metabolic profile and ventricular remodeling, reduction in arterial stiffness as 
well as reduction in atherosclerotic plaque size. Lycopene exerts favorable effects 
in patients with subclinical atherosclerosis, metabolic syndrome, hypertension, 
peripheral vascular disease, and several other cardiovascular disorders, but 
sometimes conflicting results were obtained. Clearly, more and better-designed 
studies will be necessary to improve our understanding of the positive effects 
of lycopene on vascular health and to elucidate the involved mechanisms on a 
molecular level. Future cardiovascular disease prevention strategies might include 
lycopene-enriched products, lycopene supplementation and new combinations 
including lycopene. Future studies should be focused on dietary lycopene and its 
synergistic effects with other dietary components in different study populations, 
with elevated cardiovascular risk, are highly warranted which might enable devel-
opment of functional foods useful in prevention and complementary treatment of 
 cardiovascular disorders [4].
5. Conclusion
There is a significant relationship between energy intake, fat intake, protein 
intake and carbohydrate intake with total cholesterol levels. So, there is a significant 
relationship between fat intake with LDL levels and there is a significant relation-
ship between energy intake, fat intake, protein intake and carbohydrate intake 
with triglyceride levels. About 53.3% of the treatment group subjects had total 
cholesterol levels normal (<200 mg/dL) after the study and 20% of the treat-
ment group subjects had their LDL levels normal (<100 mg/dL) after the study. 
Supplementation of 336 g (350 mL) tomato juice per day for 21 days in women with 
dyslipidemia with minimal risk can reduce total cholesterol levels by 29.6 g/dL, 
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